Skip to main content
. Author manuscript; available in PMC: 2019 Mar 18.
Published in final edited form as: Eur J Pharm Sci. 2018 Jun 22;122:134–143. doi: 10.1016/j.ejps.2018.06.022

Fig. 6.

Fig. 6

Heat map illustrating the PLIF analysis of the human P-gp inhibitors for human MDR1. X-axis denotes contact residues. Y-axis denotes functional groups of the ligand which are showing an interaction with the residue. Color scale signifies the number of interacting ligands.